CP
ABBV icon

Castleview Partners’s AbbVie ABBV Stock Holding History

Castleview Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+799
New +$172K 0.09% 213
2025
Q1 		– Sell
-438
Closed -$78.6K – 177
2024
Q4 		$78.6K Buy
438
+61
+16% +$11.2K 0.04% 283
2024
Q3 		$74.5K Sell
377
-25
-6% -$4.67K 0.04% 271
2024
Q2 		$69K Sell
402
-82
-17% -$13.6K 0.04% 284
2024
Q1 		$88.1K Buy
484
+2
+0.4% +$345 0.05% 274
2023
Q4 		$74.7K Buy
482
+202
+72% +$29.4K 0.05% 238
2023
Q3 		$41.7K Sell
280
-66
-19% -$9.69K 0.04% 277
2023
Q2 		$46.6K Buy
346
+21
+6% +$3.08K 0.04% 259
2023
Q1 		$51.8K Buy
325
+2
+0.6% +$306 0.05% 261
2022
Q4 		$52.1K Buy
323
+195
+152% +$29.9K 0.05% 226
2022
Q3 		$17K Buy
128
+73
+133% +$10.5K 0.02% 332
2022
Q2 		$4.57K Sell
55
-1,845
-97% -$282K ﹤0.01% 554
2022
Q1 		$308K Sell
1,900
-1,228,438
-100% -$178M 0.19% 113
2021
Q4 		$9.09K Buy
+1,230,338
New +$145M 0.07% 99
2021
Q2 		$1.14M Buy
+10,117
New +$1.14M 0.5% 41
2018
Q1 		$562K Buy
+5,934
New +$652K 0.46% 51

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Castleview Partners's ABBV Position: Q2 2026 in Review

Castleview Partners opened a new position in AbbVie (ABBV) in Q2 2026: 799 shares worth $201K. The stake represents 0.09% of the portfolio and ranks #213 among its holdings. This is a return to the name: Castleview Partners previously reported a position in ABBV as recently as Q4 2024.

Castleview Partners first reported a position in ABBV in Q1 2018 and has held it in 16 quarters since. The position peaked at $1.14M in Q2 2021. 1,191 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Castleview Partners held 799 shares of AbbVie worth $201K as of Q2 2026.
  • AbbVie was a new Castleview Partners position in Q2 2026.
  • AbbVie made up 0.09% of Castleview Partners's portfolio in Q2 2026, its #213 holding.
  • Castleview Partners first reported a position in AbbVie in Q1 2018 and has held it in 16 quarters since.
  • Castleview Partners's AbbVie position peaked at $1.14M in Q2 2021.
  • 1,191 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.